Klebsiella purified pneumoniae bacteriophage

Description

Presentation

Solution for oral, topical and external use in 20 ml vials. 4 bottles with instructions for use in a carton pack. 4 vials in a contoured cell package made of polyvinylchloride film. 1 contoured cell package with instructions for use in a carton pack.

Ingredients

1 ml of the drug contains:

Active ingredient:

Sterile purified filtrate of phagolysates of Klebsiella pneumoniae bacteria (with an Appelman activity of at least 10-4 ) - up to 1 ml.

Excipients:

8-hydroxyquinoline
sulfate monohydrate (preservative) in terms of 8-hydroxyquinoline sulfate -
0.0001 g/mL (content calculated).

Indications

Treatment and prevention of diseases caused by Klebsiella pneumoniae bacteria as part of complex therapy:

• diseases of the gastrointestinal tract (gastroenterocolitis, cholecystitis, pancreatitis, intestinal dysbacteriosis);
• inflammatory diseases of newborns and infants (gastroenterocolitis, intestinal dysbacteriosis, omphalitis, pemphigus, pyoderma, septicemia and septicopiemia of various localizations);
• surgical infections (wound suppuration, purulent skin lesions, burns, peritonitis, pleurisy, mastitis, osteomyelitis, abscess);
• urogenital infections (cystitis, pyelonephritis, urethritis, endometritis, vulvitis, bartolinitis, colpitis, salpingo-ophoritis);
• purulent-inflammatory diseases of the ear, throat, nose, sinuses, oral cavity, pharynx, larynx, bronchi, lungs and pleura (otitis, sore throat, pharyngitis, laryngitis, stomatitis, periodontitis, maxillary sinusitis, frontitis, bronchitis, pneumonia, pleurisy);
• post-traumatic conjunctivitis, keratoconjunctivitis, purulent corneal ulcer and iridocyclitis;
• prevention of nosocomial infections caused by Klebsiellae.